Search AMCP NewsBreaks

AMCP Regulatory NewsBreaks

Nov. 10, 2022: CMS Issues Guidance on IRA - Cost Sharing for Part B Drugs

On Nov.7, 2022, the Centers for Medicare & Medicaid Services (CMS) issued guidance about the Inflation Reduction Act (IRA) changes to cost sharing requirements. The requirements are effective April 1, 2023 for Part B drugs with prices increasing faster than inflation and July 1, 2023 for the monthly Part B cost-sharing cap for insulins.
AMCP Regulatory NewsBreaks

Nov. 2, 2022: CMS Issues Final Rule on Part B Immunosuppressive Drug Benefit

The Medicare Program; Implementing Certain Provisions of the Consolidated Appropriations Act, 2021 and other Revisions to Medicare Enrollment and Eligibility Rules final rule implements certain provisions of the Consolidated Appropriations Act, 2021 (CAA) (P.L. 116-260) and is expected to be published in the Federal Register on Nov. 3, 2022.